Pub Date : 2025-06-19eCollection Date: 2025-01-01DOI: 10.17925/HI.2025.19.1.3
Samuel Stempfel, Heli Tolppanen, Valérian Valiton, Haran Burri
Left bundle branch area pacing has been a breakthrough in pacing therapy and is being increasingly adopted. It delivers a more physiological form of pacing compared with right ventricular and biventricular pacing and also avoids the risk of perforation of the ventricular free wall. However, the therapy comes at the price of new complications related to the transseptal route for placing the lead. This article provides an update on these complications and discusses how to avoid and manage these adverse events.
{"title":"Complications with Left Bundle Branch Area Pacing: The Flip Side of the Coin.","authors":"Samuel Stempfel, Heli Tolppanen, Valérian Valiton, Haran Burri","doi":"10.17925/HI.2025.19.1.3","DOIUrl":"10.17925/HI.2025.19.1.3","url":null,"abstract":"<p><p>Left bundle branch area pacing has been a breakthrough in pacing therapy and is being increasingly adopted. It delivers a more physiological form of pacing compared with right ventricular and biventricular pacing and also avoids the risk of perforation of the ventricular free wall. However, the therapy comes at the price of new complications related to the transseptal route for placing the lead. This article provides an update on these complications and discusses how to avoid and manage these adverse events.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"19 1","pages":"26-30"},"PeriodicalIF":2.3,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12285660/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144707266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-19eCollection Date: 2025-01-01DOI: 10.17925/HI.2025.19.1.4
Bryan W Kluck, Rahul Gupta, Andrew Orzel
Background: The use of an implantable closure device with medical therapy to prevent recurrent stroke in patent foramen ovale (PFO)-associated stroke has been shown to be superior to medical therapy alone. Recently, an alternative, suture-based method also has shown promise for effective PFO closure. There has been little published data comparing the outcomes of these two technologies.
Methods: This retrospective study explores the safety and efficacy outcomes of device-based versus suture-based percutaneous PFO intervention. The occurrence of post-procedural atrial fibrillation was of primary interest. Data from 55 single-institution, single-operator PFO closure cases between 1 January 2021 and 8 April 2022 were analyzed. Closure occurred via one of two Food and Drug Administration (FDA)-approved occluders or the NobleStitch™ EL suture-based approach. Data were transcribed into a registered REDCap database for descriptive analysis. Demographics, medical history, imaging, procedural and post-procedural outcomes were the variables collected for each participant.
Results: All patients had successful PFO closure without major adverse outcomes. Overall efficacy was similar between the two groups. No patient had a residual shunt greater than grade 1. Several suture-group patients required multiple sutures for satisfactory closure. Those who had multiple sutures had no anomalous anatomic PFO features. Three patients (5%), all from the device group, developed atrial fibrillation after PFO closure.
Conclusions: This study supports the safety and efficacy of device- and suture-based approaches in PFO closure. Suture-based closure would seem a reasonable option where device-based closure raises concerns. Future studies could further explore the observed disparity of atrial fibrillation occurrence between the two PFO closure strategies.
{"title":"Retrospective Comparison of Device Versus Suture for Patent Foramen Ovale Closure.","authors":"Bryan W Kluck, Rahul Gupta, Andrew Orzel","doi":"10.17925/HI.2025.19.1.4","DOIUrl":"10.17925/HI.2025.19.1.4","url":null,"abstract":"<p><strong>Background: </strong>The use of an implantable closure device with medical therapy to prevent recurrent stroke in patent foramen ovale (PFO)-associated stroke has been shown to be superior to medical therapy alone. Recently, an alternative, suture-based method also has shown promise for effective PFO closure. There has been little published data comparing the outcomes of these two technologies.</p><p><strong>Methods: </strong>This retrospective study explores the safety and efficacy outcomes of device-based versus suture-based percutaneous PFO intervention. The occurrence of post-procedural atrial fibrillation was of primary interest. Data from 55 single-institution, single-operator PFO closure cases between 1 January 2021 and 8 April 2022 were analyzed. Closure occurred via one of two Food and Drug Administration (FDA)-approved occluders or the NobleStitch™ EL suture-based approach. Data were transcribed into a registered REDCap database for descriptive analysis. Demographics, medical history, imaging, procedural and post-procedural outcomes were the variables collected for each participant.</p><p><strong>Results: </strong>All patients had successful PFO closure without major adverse outcomes. Overall efficacy was similar between the two groups. No patient had a residual shunt greater than grade 1. Several suture-group patients required multiple sutures for satisfactory closure. Those who had multiple sutures had no anomalous anatomic PFO features. Three patients (5%), all from the device group, developed atrial fibrillation after PFO closure.</p><p><strong>Conclusions: </strong>This study supports the safety and efficacy of device- and suture-based approaches in PFO closure. Suture-based closure would seem a reasonable option where device-based closure raises concerns. Future studies could further explore the observed disparity of atrial fibrillation occurrence between the two PFO closure strategies.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"19 1","pages":"48-56"},"PeriodicalIF":2.3,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12285659/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144707270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-21eCollection Date: 2025-01-01DOI: 10.17925/HI.2025.19.1.2
Jia-Rong Wu, Abigail Latimer, Ashmita Thapa, Cynthia Arslanian-Engoren, Jennifer L Smith, Jessica Harman Thompson, Chin-Yen Lin, JungHee Kang, Muna Hammash, Muhammad I Amin, Martha J Biddle, Kyoung Suk Lee, Seongkum Heo, Debra K Moser
Introduction: Functional status is a predictor of rehospitalization and mortality in patients with heart failure (HF). The purpose of this study was to test the variables in the Multidimensional Model of Functional Status (MMFS) as determinants of functional status.
Methods: Using structural equation modelling, we analysed data from 520 patients with HF to determine the best multivariate model of functional status. In the MMFS, the potential determinants of functional status include demographic, clinical, psychosocial, behavioural and symptom burden variables. We measured functional status using the Duke Activity Status Index. Other variables were collected by standardized questionnaires and patient interviews.
Results: Patients who were older, less educated, or had greater comorbidity burden or greater symptom burden had worse functional status. Sex, body mass index, depression, anxiety and social support were indirectly associated with functional status mediated by symptom burden. Being married was indirectly associated with better functional status via the pathways of more social support and fewer depressive symptoms through lower symptom burden.
Conclusion: Multidimensional variables proposed in the MMFS were directly and indirectly associated with functional status. Among these variables, symptom burden is the most important mediator. Targeting these variables, especially symptom burden, may improve patients' functional status.
{"title":"Multidimensional Determinants of Functional Status in Patients with Heart Failure.","authors":"Jia-Rong Wu, Abigail Latimer, Ashmita Thapa, Cynthia Arslanian-Engoren, Jennifer L Smith, Jessica Harman Thompson, Chin-Yen Lin, JungHee Kang, Muna Hammash, Muhammad I Amin, Martha J Biddle, Kyoung Suk Lee, Seongkum Heo, Debra K Moser","doi":"10.17925/HI.2025.19.1.2","DOIUrl":"10.17925/HI.2025.19.1.2","url":null,"abstract":"<p><strong>Introduction: </strong>Functional status is a predictor of rehospitalization and mortality in patients with heart failure (HF). The purpose of this study was to test the variables in the Multidimensional Model of Functional Status (MMFS) as determinants of functional status.</p><p><strong>Methods: </strong>Using structural equation modelling, we analysed data from 520 patients with HF to determine the best multivariate model of functional status. In the MMFS, the potential determinants of functional status include demographic, clinical, psychosocial, behavioural and symptom burden variables. We measured functional status using the Duke Activity Status Index. Other variables were collected by standardized questionnaires and patient interviews.</p><p><strong>Results: </strong>Patients who were older, less educated, or had greater comorbidity burden or greater symptom burden had worse functional status. Sex, body mass index, depression, anxiety and social support were indirectly associated with functional status mediated by symptom burden. Being married was indirectly associated with better functional status via the pathways of more social support and fewer depressive symptoms through lower symptom burden.</p><p><strong>Conclusion: </strong>Multidimensional variables proposed in the MMFS were directly and indirectly associated with functional status. Among these variables, symptom burden is the most important mediator. Targeting these variables, especially symptom burden, may improve patients' functional status.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"19 1","pages":"41-47"},"PeriodicalIF":2.3,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12285664/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144707269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-11eCollection Date: 2025-01-01DOI: 10.17925/HI.2025.19.1.1
Rnda I Ashgar
Background: Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality among women, particularly those of childbearing age and middle-aged women, who face heightened risks due to physiological changes, stress and systemic barriers. Women of colour and those from low socioeconomic backgrounds are disproportionately affected.
Aim: This article evaluates the effectiveness of community-based participatory research (CBPR) in reducing CVD risk among midlife women, emphasizing the cultural relevance of interventions as a critical factor for success.
Methodology: Following the PRISMA guidelines, a systematic search of PubMed, Scopus and Web of Science identified 15 studies, including randomized controlled trials, practice-based participatory research (PBPRs) and mixed-methods research. These studies implemented CBPR interventions focusing on diet, physical activity, stress management and community participation for underserved populations. Outcomes measured included systolic and diastolic blood pressure, serum cholesterol, Body Mass Index (BMI) and fasting blood glucose, as well as participants' knowledge, behaviours and perceived community capacity.
Results: The analysis showed reductions in systolic and diastolic blood pressure (7 and 4 mmHg, respectively), low-density lipoprotein cholesterol (10-15 mg/dL) and BMI (0.5-1.2 kg/m²), along with increases in high-density lipoprotein cholesterol (5-8 mg/dL). Culturally tailored interventions, such as dietary adjustments, group exercise and peer support, demonstrated improved compliance and maintenance of behavioural changes. Patterns of cultural relevance, trust and community ownership emerged as key determinants of success. CBPR offers significant potential for addressing health disparities and reducing CVD risk.
Conclusion: Expanding CBPR approaches and conducting long-term interventions can enhance health equity and achieve lasting benefits across diverse populations.
背景:心血管疾病(CVD)仍然是妇女发病和死亡的主要原因,特别是育龄妇女和中年妇女,她们由于生理变化、压力和全身障碍而面临更高的风险。有色人种女性和社会经济背景较低的女性受到的影响尤为严重。目的:本文评估基于社区的参与式研究(CBPR)在降低中年妇女心血管疾病风险方面的有效性,强调干预措施的文化相关性是成功的关键因素。方法:遵循PRISMA指南,系统搜索PubMed, Scopus和Web of Science确定了15项研究,包括随机对照试验,基于实践的参与性研究(PBPRs)和混合方法研究。这些研究实施了CBPR干预措施,重点关注服务不足人群的饮食、身体活动、压力管理和社区参与。测量的结果包括收缩压和舒张压、血清胆固醇、身体质量指数(BMI)和空腹血糖,以及参与者的知识、行为和感知的社区能力。结果:分析显示收缩压和舒张压(分别为7和4 mmHg),低密度脂蛋白胆固醇(10-15 mg/dL)和BMI (0.5-1.2 kg/m²)降低,高密度脂蛋白胆固醇(5-8 mg/dL)增加。适应文化的干预措施,如饮食调整、团体锻炼和同伴支持,显示出行为改变的依从性和维持性得到改善。文化关联、信任和社区所有权的模式成为成功的关键决定因素。CBPR为解决健康差距和降低心血管疾病风险提供了巨大潜力。结论:扩大CBPR方法和开展长期干预措施可以增强卫生公平,并在不同人群中实现持久效益。
{"title":"Community-based Participatory Research in Cardiovascular Disease Prevention for Middle-aged Women: A Systematic Review.","authors":"Rnda I Ashgar","doi":"10.17925/HI.2025.19.1.1","DOIUrl":"10.17925/HI.2025.19.1.1","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality among women, particularly those of childbearing age and middle-aged women, who face heightened risks due to physiological changes, stress and systemic barriers. Women of colour and those from low socioeconomic backgrounds are disproportionately affected.</p><p><strong>Aim: </strong>This article evaluates the effectiveness of community-based participatory research (CBPR) in reducing CVD risk among midlife women, emphasizing the cultural relevance of interventions as a critical factor for success.</p><p><strong>Methodology: </strong>Following the PRISMA guidelines, a systematic search of PubMed, Scopus and Web of Science identified 15 studies, including randomized controlled trials, practice-based participatory research (PBPRs) and mixed-methods research. These studies implemented CBPR interventions focusing on diet, physical activity, stress management and community participation for underserved populations. Outcomes measured included systolic and diastolic blood pressure, serum cholesterol, Body Mass Index (BMI) and fasting blood glucose, as well as participants' knowledge, behaviours and perceived community capacity.</p><p><strong>Results: </strong>The analysis showed reductions in systolic and diastolic blood pressure (7 and 4 mmHg, respectively), low-density lipoprotein cholesterol (10-15 mg/dL) and BMI (0.5-1.2 kg/m²), along with increases in high-density lipoprotein cholesterol (5-8 mg/dL). Culturally tailored interventions, such as dietary adjustments, group exercise and peer support, demonstrated improved compliance and maintenance of behavioural changes. Patterns of cultural relevance, trust and community ownership emerged as key determinants of success. CBPR offers significant potential for addressing health disparities and reducing CVD risk.</p><p><strong>Conclusion: </strong>Expanding CBPR approaches and conducting long-term interventions can enhance health equity and achieve lasting benefits across diverse populations.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"19 1","pages":"12-19"},"PeriodicalIF":2.3,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12285662/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144707265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-18eCollection Date: 2024-01-01DOI: 10.17925/HI.2024.18.2.5
Rajkumar Natarajan, Natasha Corballis, Ioannis Merinopoulos, Vassilios S Vassiliou, Simon C Eccleshall
It has been recognized for decades that dissections occur as a mechanism of balloon angioplasty. A successful angioplasty result contains some degree of intimal splitting and disruption, which usually heals well. Nonetheless, some dissections are extensive, leading to serious ischaemic complications. The concept of therapeutic coronary dissection started evolving in the 1970s and seems to be a favourable mechanism for drug delivery in the current era of drug-coated balloons. This article will primarily focus on studies undertaken to understand the mechanism of balloon angioplasty and the morphological changes in the plaque post-balloon angioplasty. In the early days of balloon angioplasty, there was an enormous interest in dissections, mainly to prevent acute vessel closure events and to address the importance of their occurrence in relation to vessel restenosis. We will review the historical background, studies defining the clinical, angiographic and morphological patterns of the dissection spectrum and various currently evolving management strategies.
{"title":"Coronary Dissection - Back to the Future - Finding Good in the Bad!","authors":"Rajkumar Natarajan, Natasha Corballis, Ioannis Merinopoulos, Vassilios S Vassiliou, Simon C Eccleshall","doi":"10.17925/HI.2024.18.2.5","DOIUrl":"10.17925/HI.2024.18.2.5","url":null,"abstract":"<p><p>It has been recognized for decades that dissections occur as a mechanism of balloon angioplasty. A successful angioplasty result contains some degree of intimal splitting and disruption, which usually heals well. Nonetheless, some dissections are extensive, leading to serious ischaemic complications. The concept of therapeutic coronary dissection started evolving in the 1970s and seems to be a favourable mechanism for drug delivery in the current era of drug-coated balloons. This article will primarily focus on studies undertaken to understand the mechanism of balloon angioplasty and the morphological changes in the plaque post-balloon angioplasty. In the early days of balloon angioplasty, there was an enormous interest in dissections, mainly to prevent acute vessel closure events and to address the importance of their occurrence in relation to vessel restenosis. We will review the historical background, studies defining the clinical, angiographic and morphological patterns of the dissection spectrum and various currently evolving management strategies.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"18 2","pages":"14-23"},"PeriodicalIF":1.9,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11781370/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143065142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-18eCollection Date: 2024-01-01DOI: 10.17925/HI.2024.18.2.4
Yasser M Sammour, Muhammad Faraz Anwaar, Francisco Cabral-Amador, Jian Garcia, Joe Aoun, Sana Kazmi, Nadeen Faza, Stephen H Little, Michael J Reardon, Neal S Kleiman, Sachin S Goel
Tricuspid regurgitation (TR) is a common valvular heart disease that is associated with increased morbidity and mortality. Traditional surgical interventions, though definitive, carry considerable complexities and risks, especially for high-risk patients, with in-hospital mortality rates of ˜9%. This resulted in the undertreatment of many patients with TR, creating a substantial unmet need. This has stimulated the development of transcatheter techniques, such as transcatheter tricuspid valve replacement, tricuspid edge-to-edge repair, tricuspid annuloplasty, caval valve implantation and many others, which offer less-i nvasive alternatives with promising early results and sustained benefits. This review provides a contemporary outlook on different transcatheter tricuspid valve interventions in patients with severe TR and assesses the existing clinical data regarding the safety and effectiveness of these devices in a rapidly expanding space.
{"title":"Transcatheter Management of Tricuspid Regurgitation: A Review of Contemporary Evidence.","authors":"Yasser M Sammour, Muhammad Faraz Anwaar, Francisco Cabral-Amador, Jian Garcia, Joe Aoun, Sana Kazmi, Nadeen Faza, Stephen H Little, Michael J Reardon, Neal S Kleiman, Sachin S Goel","doi":"10.17925/HI.2024.18.2.4","DOIUrl":"10.17925/HI.2024.18.2.4","url":null,"abstract":"<p><p>Tricuspid regurgitation (TR) is a common valvular heart disease that is associated with increased morbidity and mortality. Traditional surgical interventions, though definitive, carry considerable complexities and risks, especially for high-risk patients, with in-hospital mortality rates of ˜9%. This resulted in the undertreatment of many patients with TR, creating a substantial unmet need. This has stimulated the development of transcatheter techniques, such as transcatheter tricuspid valve replacement, tricuspid edge-to-edge repair, tricuspid annuloplasty, caval valve implantation and many others, which offer less-i nvasive alternatives with promising early results and sustained benefits. This review provides a contemporary outlook on different transcatheter tricuspid valve interventions in patients with severe TR and assesses the existing clinical data regarding the safety and effectiveness of these devices in a rapidly expanding space.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"18 2","pages":"24-36"},"PeriodicalIF":1.9,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11781372/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143065150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-04eCollection Date: 2024-01-01DOI: 10.17925/HI.2024.18.2.2
Aditya John Binu, Nitin Kapoor
Background: Diabetic cardiomyopathy (DC) is a syndrome of heart failure occurring in patients with diabetes mellitus (DM), independent of other risk factors. It is a relatively underdiagnosed condition with a prolonged subclinical phase. There is an abundance of studies put forward to explain the underlying pathogenic mechanisms observed in this condition. This review aims to summarize the evidence available in contemporary medical literature with regard to the molecular mechanisms, abnormalities in signalling and metabolism and structural and functional abnormalities manifesting as DC. Methods: We conducted a literature search using the terms 'diabetic cardiomyopathy', 'heart failure AND Diabetes mellitus', 'Cardiomyopathy AND Diabetes mellitus'. We searched the reference lists of included studies and relevant systematic reviews. Results: In this review, we elucidate all the mechanisms that have been postulated to have a role in the pathogenesis of DC, in addition to insulin resistance, such as inflammation, renin-angiotensin-aldosterone system activation and deranged protein homeostasis. Conclusions: DC is an underrecognized cardiac complication of DM. A comprehensive knowledge of all the pathways and mediators will aid in the development of diagnostic and prognostic markers, screening protocols and novel management strategies.
{"title":"Understanding Diabetic Cardiomyopathy: Insulin Resistance and Beyond.","authors":"Aditya John Binu, Nitin Kapoor","doi":"10.17925/HI.2024.18.2.2","DOIUrl":"10.17925/HI.2024.18.2.2","url":null,"abstract":"<p><p><b>Background:</b> Diabetic cardiomyopathy (DC) is a syndrome of heart failure occurring in patients with diabetes mellitus (DM), independent of other risk factors. It is a relatively underdiagnosed condition with a prolonged subclinical phase. There is an abundance of studies put forward to explain the underlying pathogenic mechanisms observed in this condition. This review aims to summarize the evidence available in contemporary medical literature with regard to the molecular mechanisms, abnormalities in signalling and metabolism and structural and functional abnormalities manifesting as DC. <b>Methods:</b> We conducted a literature search using the terms 'diabetic cardiomyopathy', 'heart failure AND Diabetes mellitus', 'Cardiomyopathy AND Diabetes mellitus'. We searched the reference lists of included studies and relevant systematic reviews. <b>Results:</b> In this review, we elucidate all the mechanisms that have been postulated to have a role in the pathogenesis of DC, in addition to insulin resistance, such as inflammation, renin-angiotensin-aldosterone system activation and deranged protein homeostasis. <b>Conclusions:</b> DC is an underrecognized cardiac complication of DM. A comprehensive knowledge of all the pathways and mediators will aid in the development of diagnostic and prognostic markers, screening protocols and novel management strategies.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"18 2","pages":"7-13"},"PeriodicalIF":1.9,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11781369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143065163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-29eCollection Date: 2024-01-01DOI: 10.17925/HI.2024.18.2.3
Christophe Garweg, Rik Willems
Leadless pacemakers are considered one of the major technological advancements in cardiology in recent years. Many efforts are made to provide physiological atrio-ventricular (AV) pacing. With the first-generation leadless ventricular, dual, dual (VDD) pacemaker, Micra AV (Medtronic, Inc., Minneapolis, MN, USA), a high variability in AV synchrony was reported. A second generation, Micra AV2, is now available for clinical use, promising smarter and higher automatic AV synchrony. This article reviews the different improvements proposed for this new device.
无铅起搏器被认为是近年来心脏病学的主要技术进步之一。许多努力都是为了提供生理房室(AV)起搏。据报道,使用第一代无导联双心室(VDD)起搏器Micra AV (Medtronic, Inc., Minneapolis, MN, USA),室间隔同步的变异性很高。第二代,Micra AV2,现在可用于临床应用,承诺更智能和更高的自动AV同步。本文回顾了针对这种新设备提出的不同改进。
{"title":"Advancements in Leadless Pacemakers: What the Second-generation Micra AV2 Brings to Cardiac Care.","authors":"Christophe Garweg, Rik Willems","doi":"10.17925/HI.2024.18.2.3","DOIUrl":"10.17925/HI.2024.18.2.3","url":null,"abstract":"<p><p>Leadless pacemakers are considered one of the major technological advancements in cardiology in recent years. Many efforts are made to provide physiological atrio-ventricular (AV) pacing. With the first-generation leadless ventricular, dual, dual (VDD) pacemaker, Micra AV (Medtronic, Inc., Minneapolis, MN, USA), a high variability in AV synchrony was reported. A second generation, Micra AV2, is now available for clinical use, promising smarter and higher automatic AV synchrony. This article reviews the different improvements proposed for this new device.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"18 2","pages":"4-6"},"PeriodicalIF":1.9,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11781367/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143065111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-21eCollection Date: 2024-01-01DOI: 10.17925/HI.2024.18.2.1
Esra Koc Ay, Ibrahim Feyyaz Naldemir, Cem Ozde, Gulsah Akture, Seda Aytekin, Osman Kayapinar, Gürkan Karaca, Ali Kimiaei, Seyedehtina Safaei, Adnan Kaya
Background: Radial access is considered the preferred method for coronary angiography (CAG) and percutaneous coronary intervention. Radial artery thrombosis (RAT) stands out as the primary complication associated with trans-radial access. Our objective was to explore the occurrence of RAT and its associated risk factors. Method: A study encompassing 150 patients who underwent coronary interventions via radial access was conducted. Colour Doppler ultrasonography was used to assess proximal and distal radial flow rates 4-6 hours post-procedure. Patients diagnosed with RAT constituted the study group, while those without RAT were designated as controls. Results: Among the 150 patients, 20 (13.3%) developed RAT, with partial occlusions observed in 2.7% and total occlusions in 10.7%. Univariate analysis identified potential correlations between RAT and variables such as female gender, hypertension (HT), history of coronary artery disease, use of anti-thrombocyte medications, duration of compression, indication for CAG, haematocrit levels, neutrophil count, creatinine levels and estimated glomerular filtration rate. However, only HT showed a statistically significant association. Multivariate analysis confirmed HT, anti-thrombocyte drug use, duration of compression, haematocrit levels and creatinine levels as independent predictors of RAT. Conclusion: HT, anti-thrombocyte drug use, duration of compression, haematocrit levels and creatinine levels are identified as independent predictors of RAT. Standard pulse examination may not adequately detect RAT.
{"title":"Radial Artery Thrombosis and Associated Risk Factors in Patients Undergoing Radial Coronary Angiography.","authors":"Esra Koc Ay, Ibrahim Feyyaz Naldemir, Cem Ozde, Gulsah Akture, Seda Aytekin, Osman Kayapinar, Gürkan Karaca, Ali Kimiaei, Seyedehtina Safaei, Adnan Kaya","doi":"10.17925/HI.2024.18.2.1","DOIUrl":"10.17925/HI.2024.18.2.1","url":null,"abstract":"<p><p><b>Background:</b> Radial access is considered the preferred method for coronary angiography (CAG) and percutaneous coronary intervention. Radial artery thrombosis (RAT) stands out as the primary complication associated with trans-radial access. Our objective was to explore the occurrence of RAT and its associated risk factors. <b>Method:</b> A study encompassing 150 patients who underwent coronary interventions via radial access was conducted. Colour Doppler ultrasonography was used to assess proximal and distal radial flow rates 4-6 hours post-procedure. Patients diagnosed with RAT constituted the study group, while those without RAT were designated as controls. <b>Results:</b> Among the 150 patients, 20 (13.3%) developed RAT, with partial occlusions observed in 2.7% and total occlusions in 10.7%. Univariate analysis identified potential correlations between RAT and variables such as female gender, hypertension (HT), history of coronary artery disease, use of anti-thrombocyte medications, duration of compression, indication for CAG, haematocrit levels, neutrophil count, creatinine levels and estimated glomerular filtration rate. However, only HT showed a statistically significant association. Multivariate analysis confirmed HT, anti-thrombocyte drug use, duration of compression, haematocrit levels and creatinine levels as independent predictors of RAT. <b>Conclusion:</b> HT, anti-thrombocyte drug use, duration of compression, haematocrit levels and creatinine levels are identified as independent predictors of RAT. Standard pulse examination may not adequately detect RAT.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"18 2","pages":"37-43"},"PeriodicalIF":1.9,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11781368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143065149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-02eCollection Date: 2024-01-01DOI: 10.17925/HI.2024.18.2.6
Adam Ioannou
[This corrects the article DOI: 10.17925/HI.2024.18.1.5.].
[这更正了文章DOI: 10.17925/HI.2024.18.1.5.]。
{"title":"Erratum to Correct Errors in Text.","authors":"Adam Ioannou","doi":"10.17925/HI.2024.18.2.6","DOIUrl":"https://doi.org/10.17925/HI.2024.18.2.6","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.17925/HI.2024.18.1.5.].</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"18 2","pages":"3"},"PeriodicalIF":1.9,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11774339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143065146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}